http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4773985-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78941ed5a01bfbcd48376e1fdb485b19
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C10C1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C10C3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C10C1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C10C3-00
filingDate 1985-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1988-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07a1b2159eaa6b785fc244da1773af20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f16d3491e4b788dfce995b2fa87b80a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b3bcc81b1bd13b4418da89ff0114aec
publicationDate 1988-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4773985-A
titleOfInvention Method of optimizing mesophase formation in graphite and coke precursors
abstract Mesophase formation is optimized in graphite and coke precursors by a process which includes determining the values of critical chemical parameters for proposed precursors, modifying the precursors by adjusting such critical chemical parameters as oxygen content, aromaticity and functionality to within certain predetermined optimal limits and treating the resulting modified precursors to form mesophase. Oxygen content can be adjusted by oxidation or reduction of the precursor. Aromaticity can be adjusted by suitable heat treatment. Functionality can be adjusted by derivatization.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0364244-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0378901-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0348599-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0348599-A2
priorityDate 1985-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4414096-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4449586-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4457828-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3991170-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4303631-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4528087-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4600496-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4427531-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4596652-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4620919-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4460454-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4518482-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4504943-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4488957-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4474617-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4522701-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4464248-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4504455-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4581123-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4454020-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127840924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129849374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123608785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239490608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21903993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229027386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5150145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236070653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70451296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723671

Total number of triples: 54.